2Glueck CJ,Freiberg R,Glueck HI,et al, Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor,high lipoprotein, and therapy with Stanozolol[J]. Am J Hematol, 1995 ;48:213.
3Glueck CJ, Frieiberg R,Tracy T,et al. Thrombphilia and hypofibrinolysis Phthophysiologies of osteonecrosis [J]. J Clin Orthop, 1997 ;334:43.
4Harada N,Yoshimura N,Honda S.Unique regulation of expression of human aromatase in the placenta [J].J Steroid Biochem Mol Biol, 2003 ; 86(3-5) : 327.
5Saposnlk G, Barinagarrementeria F, Brnwu RD Jr, Bushnell CD, Cucchiara B, Cushman M, deVeber G, Ferro JM, Tsai FY, American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Assoeiation/Ameriean Stroke Association. Stroke, 2011, 42:1158-1192.
6Einhaupl K, Stare J, Bousser MG, De Bruijn SF, Ferro JM, Martinelli 1, Masuhr F, European Federation of Neurological Societies. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol, 2010, 17: 1229-1235.
7Medel R, Monteith SJ, Crowley RW, Dumont AS. A review of therapeutic strategies for the management of cerebral venous sinus thrombosis. Neurosurg Focus, 2009, 27:E6.
8Coutinho JM, Seelig R, Bousser MG, Canhao P, Ferro JM, Stam J. Treatment variations in cerebral venous thrombosis: an international survey. Cerebrovasc Dis, 2011, 32:298-300.
9Borhani Haghighi A, Mahmoodi M, Edgell RC, Cruz-Flores S, Ghanaati H, Jamshidi M, Zaidat OO. Mechanical thrombeetomy for cerebral venous sinus thrombosis: a comprehensive literature review. Clin Appl Thromb Hemost, 2013.[Epub ahead of print].
10Dowd CF, Malek AM, Phatouros CC, Hemphill JC 3rd. Application of a rheolytic thrombectomy device in the treatment of dural sinus thrombosis: a new technique. AJNR Am J Neuroradiol. 1999. 20:568-570.
